Clinical Trial Update: Isotretinoin for Proliferative Vitreoretinopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating isotretinoin for proliferative vitreoretinopathy has completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Wills Eye | Conditions: Proliferative Vitreoretinopathy | Phase 4 | Status: COMPLETED | Results posted: 2017-05-11